Beyond its role in the initiation of tumorigenesis, the activation of NF-κB signaling also influences hormone-dependent breast cancer progression such that the use of an IKK inhibitor as a co-treatment can promote Akt upregulation in MCF7 cells, thereby overcoming endocrine resistance(Zhou et al. 2005). The gene discussed is NFKB1; the disease is breast cancer.